Cited by 72Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission

Open access
Leonardo-Pinto, Joao Paulo, Benetti-Pinto, Cristina Laguna, Cursino, Kleber, Yela, Daniela Angerame·2017·European Journal of Obstetrics & Gynecology and Reproductive Biology

Abstract

Objective To evaluate the effectiveness of dienogest in controlling pain caused by deep infiltrating endometriosis (DIE), its influence on the quality of live (QoL) of women affected by the disease, and the effect of the drug on the volume of endometriotic lesions.Study design A prospective cohort study including 30 women with a sonographic diagnosis of DIE (intestinal and posterior fornix) treated with dienogest 2mg per day for 12 months. We evaluated the pain symptoms and the volume of the intestinal and posterior fornix lesions before and after 12 months of use of dienogest. To perform the statistical analysis, we used the Wilcoxon signed-rank test, and the relationship between the data was tested using the Spearman correlation coefficient.Results Women were on average 36.13±6.24years old. Pain symptoms most commonly reported were dyspareunia (83.3%), dysmenorrhea (73.3%), and pelvic pain (66.7%). After 12 months of treatment with dienogest, there was significant improvement of various symptoms (dyspareunia p=0.0093, dysmenorrhea p<0.0001; pelvic pain p=0.0007; and bowel pain p<0.0001), without a reduction in the volume of endometriotic nodules. There were significant improvements in the parameters that comprise the QoL (physical p<0.0001; p=0.0007 psychological) and the self-assessment of QoL (p=0.0069) and health (p=0.0001).Conclusion Dienogest is an effective medication to control symptoms of pain related to DIE, even without reducing the volume of DIE nodules.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejogrb.2017.02.015

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 38 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

  1. [5]5. Bellelis P, Dias JA, Podgaec S, Gonzales M, Baracat EC, Abrão MS. Epidemiologi- cal and clinical aspects of pelvic endometriosis-a case series. Rev da Assoc Meãdica Bras 2015;56(4):467-71.
  2. [14]14. Boujenah J, Hugues JN, Sifer C, Bricou A, Cédrin-Durnerin I, Sonigo C, et al. Endometriosis Fertility Index, or classification of the American Society of Reproductive Medicine for postoperative endometriosis patients with infertility: which is more relevant? Gynecol Obstet Fertil 2015;43(12):806-9.
  3. [17]17. McCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs 2010;70(16):2073-88.
  4. [23]23. Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Sau'de Pu'bl 2000;34(2):178-83.
  5. [36]36. Nogueira-Silva C, Costa P, Martins C, Barata S, Alho C, Calhaz-Jorge C, et al. Validation of the Portuguese Version of EHP-30 (The Endometriosis Health Profile-30). Acta Me'd Port 2015;28(3):347-56.

Cited by

Sorted by citations

Authors
Leonardo-Pinto, J. P., Benetti-Pinto, C. L., Cursino, K., & Yela, D. A.
Affiliations
Universidade Estadual de Campinas (UNICAMP) (BR)
Corresponding author
Yela, Daniela Angerame
Venue
European Journal of Obstetrics & Gynecology and Reproductive Biology
Publisher
Elsevier BV
Published
2017-04
Volume
211
Pages
108-111
ISSN
  • 0028-2243 (ISSN-L)
  • 0301-2115
OpenAlex
W2587994610
Cited by
72
References
38
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 8 · 2021: 8 · 2020: 17 · 2019: 4 · 2018: 14 · 2017: 3
FWCI
12.06
Type
journal article
Language
en
Open access
Locations
  • European Journal of Obstetrics & Gynecology and Reproductive Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
dienogest, deep infiltrating endometriosis, dyspareunia, dysmenorrhea, pelvic pain, quality of life, symptom remission
MeSH terms
Adult, Constipation, Endometriosis, Female, Hormone Antagonists, Humans, Intestinal Diseases, Nandrolone, Pain Measurement, Prospective Studies, Quality of Life, Treatment Outcome, Pelvic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review